BUDESONIDE Spirig HC caps 3 mg 50 pce

7680685160058 CH-68516 A07EA06 04.99.0.

Active substances:

Budesonidum
BUDESONIDE Spirig HC caps 3 mg 50 pce
BUDESONIDE Spirig HC caps 3 mg 50 pce
BUDESONIDE Spirig HC caps 3 mg 50 pce
1 / 3
google

Details

Product number
6851601
CPT
-
Packaging group
50
Unit
Kapsel(n)
Composition
budesonidum 3 mg, sacchari sphaerae corresp. saccharum 248.80-284.56 mg et maydis amylum, ethylcellulosum, triglycerida media, acidum oleicum, polysorbatum 80, acidi methacrylici copolymerum C, triethylis citras, talcum, Kapselhülle: E 172 (rubrum), titanii dioxidum, gelatina, E 172 (nigrum), pro capsula.

Articles (1)

Budesonid Spirig HC 3 mg, Hartkapsel mit veränderter Wirkstofffreisetzung
Kapseln
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/02/2026
Patient information leaflet
Français
05/02/2026
Patient information leaflet
Italien
05/02/2026
Professional SmPC
Allemand
05/02/2026
Professional SmPC
Français
05/02/2026
Professional SmPC
Italien
05/02/2026

Detailed composition

Substance Quantity Type Category
budesonidum
3.0 MG Substance Wirkstoff (Principe actif)
sacchari sphaerae
- Substance HNIDK
saccharum
- Substance HBESI
maydis amylum
- Substance HNIDK
ethylcellulosum
- Substance HNIDK
triglycerida media
- Substance HNIDK
acidum oleicum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
acidi methacrylici copolymerum C
- Substance HNIDK
triethylis citras
- Substance HNIDK
talcum
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK
titanii dioxidum
- Substance HNIDK
gelatina
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK

Reimbursement information

Public price
CHF 46.35
Specialties list
Yes
Generic
Yes
SL addition date: 01/02/2023

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
68516
Drug name
Budesonid Spirig HC, Hartkapsel mit veränderter Wirkstofffreisetzung
Galenic form
KAVW
ATC Code
A07EA06
Authorization status
Z
Dispensation category
B
First authorization
08/08/2022
Authorization expiration date
07/08/2027
IT number
04.99.0.
Domain
Human medicine
Field of application
Morbus Crohn

Packaging details

Description (FR)
BUDESONIDE Spirig HC caps 3 mg 50 pce
Description (DE)
BUDESONID Spirig HC Kaps 3 mg 50 Stk
Market launch
13/05/2025
Narcotic (BTM)
No

Original drug

Budenofalk 2 mg, Rektalschaum
GTIN: 7680592630019
CHF 102.55
View original

Other packaging sizes

BUDESONIDE Xiromed caps ret 3 mg bte 20 pce
None None
GTIN: 7680685160010
View
BUDESONIDE Xiromed caps ret 3 mg bte 50 pce
None None
GTIN: 7680685160027
View
BUDESONIDE Xiromed caps ret 3 mg bte 100 pce
None None
GTIN: 7680685160034
View
BUDESONIDE Spirig HC caps 3 mg 20 pce
20 KAP
GTIN: 7680685160041
View
BUDESONIDE Spirig HC caps 3 mg 100 pce
100 KAP
GTIN: 7680685160065
View
Buy us a coffee Explore the data